{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:38:36Z","timestamp":1790671116371,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.biocel.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T04:36:38Z","timestamp":1266208598000},"page":"948-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro"],"prefix":"10.1016","volume":"42","author":[{"given":"Jun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eagle S.H.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie Y.Y.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Wah","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence C.W.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-6143.2005.01143.x","article-title":"Antifibrotic agents for liver disease","volume":"6","author":"Albanis","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.biocel.2010.02.006_bib2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib3","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.biocel.2010.02.006_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"23","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","article-title":"PPAR\u03b3 agonists inhibit TGF-\u03b2-induced pulmonary myofibroblast differentiation and collagen production:implications for therapy of lung fibrosis","volume":"288","author":"Burgess","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.biocel.2010.02.006_bib6","first-page":"105","article-title":"Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice","volume":"19","author":"Da Silva Morais","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.biocel.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"4","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib8","first-page":"1828","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"28","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2010.02.006_bib9","first-page":"G947","article-title":"Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF","volume":"264","author":"Friedman","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biocel.2010.02.006_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.510310117","article-title":"Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factorinduced proliferation of human hepatic stellate cells","volume":"31","author":"Galli","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","volume":"122","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.biocel.2010.02.006_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","article-title":"Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases","volume":"28","author":"Gressner","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.biocel.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01324802","article-title":"The hepatic stellate (Ito) cell: its role in human liver disease","volume":"430","author":"Hautekeete","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.biocel.2010.02.006_bib16","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2010.02.006_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2001-17557","article-title":"Hepatic stellate cell behavior during resolution of liver injury","volume":"21","author":"Iredale","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.biocel.2010.02.006_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2004.01.038","article-title":"Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet","volume":"315","author":"Kawaguchi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1101\/gad.10.9.1096","article-title":"ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism","volume":"10","author":"Kim","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.biocel.2010.02.006_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/bbrc.2002.6385","article-title":"Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride","volume":"291","author":"Kon","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2005.079194","article-title":"Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats","volume":"55","author":"Leclercq","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.biocel.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.64.070195.002021","article-title":"Transcriptional regulation of gene expression during adipocyte differentiation","volume":"64","author":"MacDougald","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biocel.2010.02.006_bib23","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1172\/JCI114886","article-title":"Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo","volume":"86","author":"Maher","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2010.02.006_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","volume":"119","author":"Marra","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"35715","DOI":"10.1074\/jbc.M006577200","article-title":"Peroxisome proliferator-activated receptors and hepatic stellate cell activation","volume":"75","author":"Miyahara","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2010.02.006_bib26","doi-asserted-by":"crossref","first-page":"3116S","DOI":"10.1093\/jn\/130.12.3116S","article-title":"Hormonal signaling and transcriptional control of adipocyte differentiation","volume":"130","author":"Morrison","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.biocel.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/00365520802530861","article-title":"Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice","volume":"44","author":"Nan","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.biocel.2010.02.006_bib28","first-page":"1008","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","article-title":"The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years","volume":"11","author":"Powell","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1024184826728","article-title":"A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue","volume":"248","author":"Riccalton-Banks","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.biocel.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2310\/JIM.0b013e31816464e9","article-title":"The antifibrogenic potential of PPARgamma ligands in pulmonary fibrosis","volume":"56","author":"Sime","year":"2008","journal-title":"J Investig Med"},{"key":"10.1016\/j.biocel.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.imbio.2008.07.015","article-title":"The many faces of PPARgamma: anti-inflammatory by any means?","volume":"213","author":"Szanto","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.biocel.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","article-title":"Diagnosis and therapy of nonalcoholic steatohepatitis","volume":"134","author":"Torres","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2010.02.006_bib35","first-page":"G581","article-title":"Effects of dietary polyunsaturated fat on ethanol-induced Ito cell activation","volume":"270","author":"Tsukamoto","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biocel.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.1840070609","article-title":"Biochemical characteristics of isolated rat liver stellate cells","volume":"7","author":"Yamada","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.20994","article-title":"Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo","volume":"43","author":"Yu","year":"2006","journal-title":"Hepatology"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272510000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272510000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:51:45Z","timestamp":1787151105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272510000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1357272510000634"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2010.02.006","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2010.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}